CCL2 and neoplasm: Consistently, the depletion of resKCs by clodronate liposome treatment rendered mice extremely susceptible to bacterial infections, whereas liver anti-tumor immunity was not compromised at all (rather, it was enhanced) as the number of recMφs was increased, presumably due to resKCs producing MCP-1 prior to apoptosis [2].